|
1
|
TP53 mutations in serous tubal intraepithelial carcinoma and concurrent pelvic high-grade serous carcinoma--evidence supporting the clonal relationship of the two lesions.
|
J Pathol
|
2011
|
1.94
|
|
2
|
Role of KRAS and BRAF gene mutations in mucinous ovarian carcinoma.
|
Gynecol Oncol
|
2003
|
1.74
|
|
3
|
The revised 2009 FIGO staging system for endometrial cancer: should the 1988 FIGO stages IA and IB be altered?
|
Int J Gynecol Cancer
|
2011
|
1.60
|
|
4
|
Diagnosis of serous tubal intraepithelial carcinoma based on morphologic and immunohistochemical features: a reproducibility study.
|
Am J Surg Pathol
|
2011
|
1.37
|
|
5
|
Expression of WT1, CA 125, and GCDFP-15 as useful markers in the differential diagnosis of primary ovarian carcinomas versus metastatic breast cancer to the ovary.
|
Am J Surg Pathol
|
2005
|
1.26
|
|
6
|
Adjuvant gemcitabine plus docetaxel for completely resected stages I-IV high grade uterine leiomyosarcoma: Results of a prospective study.
|
Gynecol Oncol
|
2009
|
1.23
|
|
7
|
Interobserver and intraobserver variability of a two-tier system for grading ovarian serous carcinoma.
|
Am J Surg Pathol
|
2007
|
1.23
|
|
8
|
Application of immunohistochemistry to gynecologic pathology.
|
Arch Pathol Lab Med
|
2008
|
1.14
|
|
9
|
Variants in hormone biosynthesis genes and risk of endometrial cancer.
|
Cancer Causes Control
|
2008
|
1.14
|
|
10
|
Phytoestrogen consumption and endometrial cancer risk: a population-based case-control study in New Jersey.
|
Cancer Causes Control
|
2009
|
1.13
|
|
11
|
"Low-grade leiomyosarcoma" and late-recurring smooth muscle tumors of the uterus: a heterogenous collection of frequently misdiagnosed tumors associated with an overall favorable prognosis relative to conventional uterine leiomyosarcomas.
|
Am J Surg Pathol
|
2011
|
1.11
|
|
12
|
Retroperitoneal nodal metastasis in primary and recurrent granulosa cell tumors of the ovary.
|
Gynecol Oncol
|
2006
|
1.10
|
|
13
|
Histopathologic prognostic factors in stage I leiomyosarcoma of the uterus: a detailed analysis of 27 cases.
|
Am J Surg Pathol
|
2011
|
0.99
|
|
14
|
Intraperitoneal chemotherapy for ovarian carcinoma: results of long-term follow-up.
|
J Clin Oncol
|
2002
|
0.99
|
|
15
|
Lysophosphatidic acid acyltransferase-beta is a prognostic marker and therapeutic target in gynecologic malignancies.
|
Cancer Res
|
2005
|
0.89
|
|
16
|
The value of MR imaging when the site of uterine cancer origin is uncertain.
|
Radiology
|
2011
|
0.82
|
|
17
|
Endocervical involvement in endometrial adenocarcinoma is not prognostically significant and the pathologic assessment of the pattern of involvement is not reproducible.
|
Gynecol Oncol
|
2012
|
0.79
|
|
18
|
The significance of cytological mesothelial atypia diagnosed from peritoneal washings performed during risk-reducing salpingo-oophorectomy.
|
Gynecol Oncol
|
2006
|
0.79
|
|
19
|
Immunophenotypic and genotypic characterization of progression in follicular lymphomas.
|
Appl Immunohistochem Mol Morphol
|
2004
|
0.78
|
|
20
|
Novel Fumarate Hydratase Mutation in Siblings With Early Onset Uterine Leiomyomas and Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome.
|
Int J Gynecol Pathol
|
2017
|
0.75
|
|
21
|
Giant cell tumor of uterus resembling osseous giant cell tumor: case report and review of literature.
|
Int J Surg Pathol
|
2012
|
0.75
|
|
22
|
Interobserver Reproducibility Among Gynecologic Pathologists in Diagnosing Heterologous Osteosarcomatous Component in Gynecologic Tract Carcinosarcomas.
|
Int J Gynecol Pathol
|
2017
|
0.75
|